会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTION USING HEAT SHOCK PROTEINS
    • 治疗和预防使用热休克蛋白抑制剂的方法和组合物
    • WO2001017554A1
    • 2001-03-15
    • PCT/US2000/024711
    • 2000-09-08
    • FORDHAM UNIVERSITYSRIVASTAVA, Pramod, K.CHANDAWARKAR, Rajiv, Y.
    • SRIVASTAVA, Pramod, K.CHANDAWARKAR, Rajiv, Y.
    • A61K39/385
    • A61K39/001A61K2039/6043A61K2039/622
    • Methods for treatment and prevention of graft rejection, e.g., in response to tissue or organ transplantation, are disclosed. The disclosed methods comprise administration of compositions of complexes of heat shock/stress protein (hsps) including, but not limited to, hsp70, hsp90, and gp96, either alone or in combination with each other, noncovalently bound to antigenic molecules, to suppress the immune response to the grafted tissue or organ. In addition, administration of compositions containing un-complexed stress proteins (i.e., free of antigenic molecules) to suppress the immune response to the grafted tissue or organ are also disclosed. The invention encompasses administration of heat shock proteins before, after, or both before and after transplantation or grafting. In addition, the invention encompasses administration of donor tissue sample prior to administration of heat shock protein and subsequent transplantation or grafting.
    • 公开了用于治疗和预防移植排斥反应的方法,例如响应于组织或器官移植。 所公开的方法包括非共价结合抗原分子的单独或彼此组合的包括但不限于hsp70,hsp90和gp96的热休克/应激蛋白(hsps)复合物的组合物,以抑制 对移植组织或器官的免疫应答。 此外,还公开了含有非复合应激蛋白(即,不含抗原性分子)的组合物的给药以抑制对移植组织或器官的免疫应答。 本发明包括在移植或移植之前,之后或之前施用热休克蛋白。 此外,本发明包括在给予热休克蛋白之前施用供体组织样品,随后进行移植或移植。